TSCAN THERAPEUTICS, INC. (TCRX)

0.75 +0.53% (+0.00)

Over 6M: -28.2%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

0.75 1 1.25
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 2.4M Q3 '21 — Operating Cash Flow: -13.6M Q3 '21 — Free Cash Flow: -14.5M Q3 '21 — Net Income: -15.8M Q4 '21 — Revenue: 2.9M Q4 '21 — Operating Cash Flow: -14.4M Q4 '21 — Free Cash Flow: -16.6M Q4 '21 — Net Income: -14.2M Q1 '22 — Revenue: 3M Q1 '22 — Operating Cash Flow: -20.1M Q1 '22 — Free Cash Flow: -20.7M Q1 '22 — Net Income: -16.2M Q2 '22 — Revenue: 4.1M Q2 '22 — Operating Cash Flow: -13.4M Q2 '22 — Free Cash Flow: -15.3M Q2 '22 — Net Income: -15.1M Q3 '22 — Revenue: 3.4M Q3 '22 — Operating Cash Flow: -17M Q3 '22 — Free Cash Flow: -17.4M Q3 '22 — Net Income: -16.2M Q4 '22 — Revenue: 3.1M Q4 '22 — Operating Cash Flow: -16M Q4 '22 — Free Cash Flow: -17.4M Q4 '22 — Net Income: -18.7M Q1 '23 — Revenue: 6.8M Q1 '23 — Operating Cash Flow: -23.6M Q1 '23 — Free Cash Flow: -24.4M Q1 '23 — Net Income: -22.6M Q2 '23 — Revenue: 3.1M Q2 '23 — Operating Cash Flow: -22M Q2 '23 — Free Cash Flow: -22.4M Q2 '23 — Net Income: -24M Q3 '23 — Revenue: 3.9M Q3 '23 — Operating Cash Flow: 8M Q3 '23 — Free Cash Flow: 6.6M Q3 '23 — Net Income: -23M Q4 '23 — Revenue: 7.2M Q4 '23 — Operating Cash Flow: -23.8M Q4 '23 — Free Cash Flow: -24.2M Q4 '23 — Net Income: -19.6M Q1 '24 — Revenue: 566K Q1 '24 — Operating Cash Flow: -29.3M Q1 '24 — Free Cash Flow: -30M Q1 '24 — Net Income: -30.1M Q2 '24 — Revenue: 536K Q2 '24 — Operating Cash Flow: -26.2M Q2 '24 — Free Cash Flow: -27.1M Q2 '24 — Net Income: -31.7M Q3 '24 — Revenue: 1M Q3 '24 — Operating Cash Flow: -27.9M Q3 '24 — Free Cash Flow: -29.3M Q3 '24 — Net Income: -29.9M Q4 '24 — Revenue: 665K Q4 '24 — Operating Cash Flow: -27.4M Q4 '24 — Free Cash Flow: -28.3M Q4 '24 — Net Income: -35.8M Q1 '25 — Revenue: 2.2M Q1 '25 — Operating Cash Flow: -37.6M Q1 '25 — Free Cash Flow: -39.1M Q1 '25 — Net Income: -34.1M Q2 '25 — Revenue: 3.1M Q2 '25 — Operating Cash Flow: -33.3M Q2 '25 — Free Cash Flow: -34.5M Q2 '25 — Net Income: -37M Q3 '25 — Revenue: 2.5M Q3 '25 — Operating Cash Flow: -32.5M Q3 '25 — Free Cash Flow: -33.9M Q3 '25 — Net Income: -35.7M Q4 '25 — Revenue: 2.6M Q4 '25 — Operating Cash Flow: -32M Q4 '25 — Free Cash Flow: -32.2M Q4 '25 — Net Income: -23M Q1 '26 — Revenue: 982K Q1 '26 — Operating Cash Flow: -24.3M Q1 '26 — Free Cash Flow: -24.3M Q1 '26 — Net Income: -28.7M Q2 '26 — Revenue: 1.1M Q2 '26 — Operating Cash Flow: -27.5M Q2 '26 — Free Cash Flow: -28M Q2 '26 — Net Income: -30.4M -30M -20M -10M 0 10M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.7
SBC / sales 138.4%
Oper. margin -1695.1%
Accruals -0.84%
Asset turnover 0.041×
EBITDA margin -1654.6%
FCF margin -1665.6%
OCF margin -1635.2%
ROA -68.7%
ROCE -85.8%
ROE -170.6%
Gross margin —
OCF / EBIT —
OE margin —
Profit margin —
ROIC —

3 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.7
RPO / sales 0.082×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -43.2×
Cash / Debt 2.6×
Debt payback 0.0 yr
Quick ratio 3.4×
Debt / Eq 0.64×
Cash runway 0.6 yr
F-score 2.2 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.6
Sales CAGR 4Y +0.45%
Sales/sh Y/Y -11.9%
Sales Q/Q -65.8%
Shares change +15.9%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.